Veradermics is trading at $103.28, up 4.3%, based on the provided live price; searches on September 14, 2026 found no clear company-specific catalyst.

  • Searches found no clear announcement, earnings release, analyst action, or other direct explanation.
  • Coverage mainly references earlier positive VDPHL01 clinical-trial updates and conference activity, not a new September 14 event.
  • Broader indexes are slightly lower, so market sentiment does not clearly explain the gain.